Genpact Limited (NYSE:G) Given Consensus Rating of “Hold” by Brokerages

Shares of Genpact Limited (NYSE:G) have been given a consensus rating of “Hold” by the eight ratings firms that are covering the firm, Marketbeat.com reports. Six investment analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $44.50.

Several analysts recently issued reports on G shares. Jefferies Financial Group raised shares of Genpact from a “hold” rating to a “buy” rating and upped their price objective for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Robert W. Baird increased their price target on shares of Genpact from $44.00 to $48.00 and gave the company a “neutral” rating in a report on Friday, November 8th. Needham & Company LLC increased their price target on shares of Genpact from $42.00 to $55.00 and gave the company a “buy” rating in a report on Monday, November 11th. Finally, TD Cowen increased their price target on shares of Genpact from $40.00 to $45.00 and gave the company a “hold” rating in a report on Friday, November 8th.

Insider Buying and Selling

In other Genpact news, SVP Piyush Mehta sold 12,000 shares of Genpact stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the transaction, the senior vice president now owns 151,182 shares of the company’s stock, valued at approximately $6,475,125.06. The trade was a 7.35 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction that occurred on Friday, December 13th. The shares were sold at an average price of $44.60, for a total transaction of $606,560.00. Following the completion of the transaction, the chief executive officer now directly owns 267,404 shares in the company, valued at approximately $11,926,218.40. The trade was a 4.84 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 35,058 shares of company stock valued at $1,558,675 in the last 90 days. 2.80% of the stock is owned by insiders.

Institutional Trading of Genpact

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Franklin Resources Inc. raised its holdings in shares of Genpact by 6.5% in the third quarter. Franklin Resources Inc. now owns 4,148,185 shares of the business services provider’s stock valued at $162,318,000 after purchasing an additional 252,674 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Genpact by 12.6% in the third quarter. Geode Capital Management LLC now owns 3,691,406 shares of the business services provider’s stock valued at $148,142,000 after purchasing an additional 413,646 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Genpact by 192.8% in the third quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider’s stock valued at $122,701,000 after purchasing an additional 2,060,595 shares during the last quarter. Tandem Investment Advisors Inc. raised its holdings in shares of Genpact by 390.5% in the fourth quarter. Tandem Investment Advisors Inc. now owns 2,129,915 shares of the business services provider’s stock valued at $91,480,000 after purchasing an additional 1,695,706 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its holdings in shares of Genpact by 0.3% in the fourth quarter. Bank of New York Mellon Corp now owns 1,326,474 shares of the business services provider’s stock valued at $56,972,000 after purchasing an additional 4,453 shares during the last quarter. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Genpact Stock Down 0.0 %

Genpact stock opened at $49.35 on Friday. The firm’s 50 day moving average price is $44.86 and its two-hundred day moving average price is $41.09. Genpact has a twelve month low of $30.23 and a twelve month high of $49.68. The firm has a market cap of $8.70 billion, a PE ratio of 13.56, a P/E/G ratio of 1.61 and a beta of 1.20. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 1.85.

Genpact (NYSE:G) last announced its quarterly earnings results on Thursday, November 7th. The business services provider reported $0.75 EPS for the quarter, topping the consensus estimate of $0.71 by $0.04. The company had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.19 billion. Genpact had a net margin of 14.22% and a return on equity of 21.85%. During the same quarter in the prior year, the business posted $0.67 EPS. On average, research analysts predict that Genpact will post 2.94 EPS for the current fiscal year.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.